Los Angeles Capital Management & Equity Research Inc. held its position in shares of Humana Inc. (NYSE:HUM) during the second quarter, Holdings Channel reports. The fund owned 1,385 shares of the insurance provider’s stock at the end of the second quarter. Los Angeles Capital Management & Equity Research Inc.’s holdings in Humana were worth $249,000 as of its most recent filing with the SEC.
Other institutional investors have also made changes to their positions in the company. Renaissance Technologies LLC increased its position in shares of Humana by 246.3% in the first quarter. Renaissance Technologies LLC now owns 446,000 shares of the insurance provider’s stock worth $81,596,000 after buying an additional 317,200 shares during the period. Arrowgrass Capital Partners US LP increased its position in shares of Humana by 1.8% in the first quarter. Arrowgrass Capital Partners US LP now owns 2,878,848 shares of the insurance provider’s stock worth $526,685,000 after buying an additional 51,267 shares during the period. Orbis Allan Gray Ltd acquired a new position in shares of Humana during the first quarter worth $38,209,000. Hermes Investment Management Ltd. increased its position in shares of Humana by 8.6% in the second quarter. Hermes Investment Management Ltd. now owns 208,145 shares of the insurance provider’s stock worth $37,441,000 after buying an additional 16,500 shares during the period. Finally, Zurich Insurance Group Ltd FI acquired a new position in shares of Humana during the first quarter worth $3,553,000. 93.24% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Humana Inc. (NYSE:HUM) traded up 0.58% on Friday, hitting $176.84. 244,429 shares of the stock traded hands. The firm has a market cap of $26.36 billion, a P/E ratio of 27.17 and a beta of 0.91. Humana Inc. has a 52 week low of $150.00 and a 52 week high of $191.65. The stock has a 50-day moving average price of $177.23 and a 200 day moving average price of $176.36.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The business earned $14 billion during the quarter, compared to analyst estimates of $13.59 billion. During the same period in the previous year, the business earned $1.67 EPS. Humana’s revenue was up 2.0% compared to the same quarter last year. Equities research analysts predict that Humana Inc. will post $9.26 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s payout ratio is 18.18%.
A number of equities analysts have weighed in on HUM shares. Zacks Investment Research downgraded Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, September 21st. JPMorgan Chase & Co. downgraded Humana from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $196.00 to $150.00 in a research report on Friday, July 8th. Evercore ISI started coverage on Humana in a research report on Thursday, September 22nd. They issued a “buy” rating and a $200.00 target price on the stock. Argus reaffirmed a “hold” rating on shares of Humana in a research report on Tuesday, August 23rd. Finally, Wolfe Research raised Humana to an “outperform” rating and set a $192.00 target price on the stock in a research report on Thursday, July 21st. Six analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Humana currently has a consensus rating of “Buy” and an average price target of $200.93.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.